Business Standard

Temasek to invest Rs 540 cr in True North-backed healthcare firm Integrace

Integrace is an orthopaedic and gynaecology-focused formulation player ranking among the top five in its area. It manages 20 brands and recently acquired two brands in Women's Health from Zydus Cadila

Healthcare
Premium

In the pharma ind The company brands are market leaders in core orthopedic and gynaecology segments like bone and joint disorders, pain management, and pregnancy and women’s nutrition. ustry, vaccine innovation and the lifecycle of trials reduce from

Raghavendra Kamath Mumbai
Singapore-based investor Temasek will invest Rs 540 crore in Integrace, a therapy-based healthcare company that is majority owned by home-grown private equity company True North.

True North said it has signed definitive documents with Temasek to invest Rs 540 crore for a stake in Integrace. True North held a significant majority stake in the company through its initial investment in October 2018 and will continue to hold majority stake after the partial stake sale.

Integrace is an orthopaedic and gynaecology-focused domestic formulation player ranking among the top five players in the therapies it operates. The firm currently manages over 20

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 04 2021 | 3:07 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com